U.S. FDA panel weighs COVID vaccines for children as young as 6 months

Published by
Reuters

(Reuters) – Advisers to the U.S Food and Drug Administration on Wednesday will vote on whether to recommend authorization of two COVID-19 vaccines for the millions of children ages five years and under, an important step toward immunizing a group that has not been eligible for the shots during the pandemic. The U.S. government is planning for a June 21 start to its under-5 vaccination campaign should the vaccines from Moderna Inc and Pfizer/BioNTech receive FDA authorization, White House COVID-19 response coordinator Ashish Jha said last week. Once the FDA authorizes the vaccines for the age g…

Read More

Leave a Reply